Ethics Case: When is Non-Invasive Prenatal Diagnostic Testing Beneficial?

Authors: Nwanodi O*

DOI: 10.23880/oajg-16000S3-003

Special Issue 3

Abstract

Recommended for antepartum screening in pregnancies of high-risk women, non-invasive prenatal testing (NIPT) is poised for wider use. A holistic approach to pregnancy requires that paternal genetic contribution be considered when evaluating genetic risk. High-risk male contribution to a pregnancy from advanced paternal age may be best screened for by NIPT. Given subtly older maternal ages, NIPT also provides a means for non-communicable disease early diagnosis.

Keywords: Advanced Paternal Age; Advanced Maternal Age; Aneuploidy Screening; Antepartum Screening; Autonomy; Beneficence; Cell-Free Fetal DNA; Choriocarcinoma; Cost-Effectiveness; Down’s Syndrome; Egalitarianism; Informed Consent; Libertarianism; Non-Invasive Prenatal Testing; Nonmaleficence; Single-Base Substitutions; Trisomy 13; Trisomy 18; Trisomy 21; Utilitarianism

View PDF